Ameriprise’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-301,521
| Closed | -$8.84M | – | 3806 |
|
|
2017
Q3 | $8.84M | Sell |
301,521
-92,795
| -24% | -$2.6M | ﹤0.01% | 1677 |
|
|
2017
Q2 | $10.4M | Sell |
394,316
-306,204
| -44% | -$7.53M | 0.01% | 1527 |
|
|
2017
Q1 | $16.4M | Sell |
700,520
-169,150
| -19% | -$4.17M | 0.01% | 1153 |
|
|
2016
Q4 | $21.9M | Sell |
869,670
-278,600
| -24% | -$7.03M | 0.01% | 945 |
|
|
2016
Q3 | $32.2M | Buy |
1,148,270
+30,976
| +3% | +$794K | 0.02% | 684 |
|
|
2016
Q2 | $27.6M | Sell |
1,117,294
-1,003,883
| -47% | -$24.9M | 0.02% | 745 |
|
|
2016
Q1 | $46.9M | Buy |
2,121,177
+199,474
| +10% | +$5.31M | 0.03% | 497 |
|
|
2015
Q4 | $67.3M | Sell |
1,921,703
-56,947
| -3% | -$1.78M | 0.04% | 394 |
|
|
2015
Q3 | $56.3M | Sell |
1,978,650
-169,853
| -8% | -$5.71M | 0.03% | 436 |
|
|
2015
Q2 | $71.5M | Buy |
2,148,503
+193,117
| +10% | +$5.93M | 0.04% | 400 |
|
|
2015
Q1 | $55.1M | Buy |
1,955,386
+298,003
| +18% | +$7.41M | 0.03% | 491 |
|
|
2014
Q4 | $34.3M | Sell |
1,657,383
-1,287
| -0.1% | -$30.6K | 0.02% | 680 |
|
|
2014
Q3 | $40.5M | Buy |
1,658,670
+785,483
| +90% | +$20.8M | 0.02% | 590 |
|
|
2014
Q2 | $25M | Buy |
873,187
+28,311
| +3% | +$787K | 0.01% | 898 |
|
|
2014
Q1 | $23.6M | Buy |
844,876
+489,996
| +138% | +$12M | 0.01% | 891 |
|
|
2013
Q4 | $7.63M | Buy |
354,880
+240,637
| +211% | +$4.37M | ﹤0.01% | 1696 |
|
|
2013
Q3 | $1.52M | Sell |
114,243
-188,455
| -62% | -$2.54M | ﹤0.01% | 2548 |
|
|
2013
Q2 | $4.2M | Buy |
+302,698
| New | +$4.29M | ﹤0.01% | 1985 |
|
Ameriprise's PMC Position: Q4 2017 in Review
Ameriprise sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 301,521 shares — an estimated $8.84M sold.
Ameriprise first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $71.5M in Q2 2015. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Ameriprise reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Ameriprise sold 301,521 PharMerica Corporation shares in Q4 2017, an estimated $8.84M.
- Ameriprise first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Ameriprise's PharMerica Corporation position peaked at $71.5M in Q2 2015.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Ameriprise's 13F filing for Q4 2017, filed 12 Feb 2018.